Jackson Creek Investment Advisors LLC Sells 23 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

Jackson Creek Investment Advisors LLC lessened its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 3.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 673 shares of the biopharmaceutical company’s stock after selling 23 shares during the period. Jackson […]

Related Keywords

Andrewj Murphy ,Arthurf Ryan , ,Regeneron Pharmaceuticals Profile ,Regeneron Pharmaceuticals Price Performance ,Cantor Fitzgerald ,Eudaimonia Advisors ,Quarter For Regeneron Pharmaceuticals ,Clearview Wealth Advisors ,Jackson Creek Investment Advisors ,Wealth Management ,Regeneron Pharmaceuticals Inc ,Securities Exchange Commission ,Regeneron Pharmaceuticals ,News Ratings For Regeneron Pharmaceuticals Daily ,Exchange Commission ,Sutton Wealth Advisors Inc ,Nasdaq ,Free Report ,Creek Investment Advisors ,Wealth Advisors ,Truist Financial ,Get Free Report ,Director Arthur ,Regeneron Pharmaceuticals Daily ,Nasdaq Regn ,Regn ,Medical ,75886f10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,